Novilytic
West Lafayette, US · Indiana LLC · 1 known investors
Founders & leadership
RW
Rich WynneExecutive
PC
Paul C DreierNamed on SEC filing
FE
Fred E RegnierNamed on SEC filing
JA
Jiri AdamecNamed on SEC filing
Board
AS
Alan SymonsBoard director
EW
Edward W WoenkerBoard director
TE
Timothy E WoenkerBoard director
JE
Johnston ErwinBoard director
JE
Jonathan EdwardsenBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$1.5M disclosed across 2 rounds · 2021–2025
▶$530.8KraisedDec 2025 · 8 investors · BiotechnologyRule 506(b)
▶$530.8KraisedDec 2025 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Johnston ErwinDirector
- Paul C DreierExecutive Officer, Director, Promoter
- Jonathan EdwardsenDirector
- Rich WynneExecutive Officer
- Alan SymonsDirector
- Edward W WoenkerDirector
- Timothy E WoenkerDirector
- Fred E RegnierExecutive Officer, Director
- Offering amount
- $1M
- Amount sold
- $530.8K
- Minimum investment
- $25K
- Proceeds to insiders
- $75K
- First sale
- Dec 2025
- Incorporated
- Limited Liability Company, Indiana
- Federal exemptions
- 06b
▶$950KraisedApr 2021 · 7 investors · BiotechnologyRule 506(b)
▶$950KraisedApr 2021 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Edward WoenkerDirector
- Fred RegnierDirector
- Paul DreierExecutive Officer, Director
- Timothy WoenkerDirector
- Jiri AdamecDirector
- Offering amount
- $3M
- Amount sold
- $950K
- Minimum investment
- $50K
- Proceeds to insiders
- $161.2K
- First sale
- Mar 2021
- Incorporated
- Limited Liability Company, Indiana
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 4
by search overlap
Fortis Life Sciences8 shared keywordsFortis Life Sciences develops and manufactures Bethyl-branded ELISA kits and related reagents, buffers, and antibodies for detecting target proteins in research and diagnostic applications. The kits cover human and veterinary targets and are made in the USA using the company's own antibodies.
IQVIA6 shared keywordsIQVIA provides data, analytics, AI, and technology-driven services for life sciences and healthcare organizations, spanning clinical development, real world evidence generation, and commercial execution. It offers integrated solutions for clinical trials, regulatory and safety compliance, and market analytics, including agentic AI products for commercial and R&D teams.
Intralytix5 shared keywords
Veracyte3 shared keywordsVeracyte develops genomic diagnostic tests for cancer, offering laboratory developed tests for thyroid, prostate, bladder, and breast cancers performed in its CLIA-certified, high-complexity labs. Its tests analyze each patient's tumor biology to help clinicians make personalized treatment decisions.
Companies competing with Novilytic for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- Who are Novilytic's investors?
- Novilytic's investors include Elevate Ventures.
- How much funding has Novilytic raised?
- Novilytic has disclosed $1.5M raised across 2 rounds.
- Where is Novilytic headquartered?
- Novilytic is headquartered in West Lafayette, US.